|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/18/21 Syneos Health, Inc. 10-K 12/31/20 130:23M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 2.16M
2: EX-10.16 Ex-10.16.2 First Amendment to the Purchase and HTML 68K
Sale Agreement
3: EX-10.16 Ex-10.16.5 Fifth Amendment Purchase and Sale HTML 100K
Agreement
4: EX-10.17 Ex-10.17.11 Tenth Amendment Receivables Financing HTML 237K
Agreement
5: EX-21.1 EX-21.1 Subsidiaries of the Registrant HTML 84K
6: EX-23.1 EX-23.1 Consent of Deloitte & Touche LLP HTML 34K
7: EX-31.1 EX-31.1 Section 302 CEO Certification HTML 38K
8: EX-31.2 EX-31.2 Section 302 CFO Certification HTML 38K
9: EX-32.1 EX-32.1 Section 906 CEO Certification HTML 37K
10: EX-32.2 EX-32.2 Section 906 CFO Certification HTML 37K
17: R1 Cover Page HTML 99K
18: R2 Consolidated Statements of Income HTML 112K
19: R3 Consolidated Statements of Comprehensive Income HTML 52K
(Loss)
20: R4 Consolidated Statements of Comprehensive Income HTML 40K
(Loss) (Parenthetical)
21: R5 Consolidated Balance Sheets HTML 132K
22: R6 Consolidated Balance Sheets (Parenthetical) HTML 52K
23: R7 Consolidated Statements of Cash Flows HTML 136K
24: R8 Consolidated Statements of Shareholders' Equity HTML 84K
25: R9 Basis of Presentation and Summary of Significant HTML 129K
Accounting Policies
26: R10 Financial Statement Details HTML 498K
27: R11 Business Combinations and Divestitures HTML 89K
28: R12 Long-Term Debt Obligations HTML 127K
29: R13 Leases HTML 218K
30: R14 Derivatives HTML 71K
31: R15 Fair Value Measurements HTML 255K
32: R16 Restructuring and Other Costs HTML 150K
33: R17 Shareholders' Equity HTML 159K
34: R18 Earnings Per Share HTML 93K
35: R19 Income Taxes HTML 376K
36: R20 Revenue from Contracts with Customers HTML 42K
37: R21 Segment Information HTML 165K
38: R22 Operations by Geographic Location HTML 98K
39: R23 Concentration of Credit Risk HTML 39K
40: R24 Related-Party Transactions HTML 40K
41: R25 Commitments and Contingencies HTML 45K
42: R26 Share-Based Compensation HTML 156K
43: R27 Employee Benefit Plans HTML 54K
44: R28 Basis of Presentation and Summary of Significant HTML 187K
Accounting Policies (Policies)
45: R29 Basis of Presentation and Summary of Significant HTML 111K
Accounting Policies (Tables)
46: R30 Financial Statement Details (Tables) HTML 586K
47: R31 Business Combinations and Divestitures (Tables) HTML 84K
48: R32 Long-Term Debt Obligations (Tables) HTML 113K
49: R33 Leases (Tables) HTML 277K
50: R34 Derivatives (Tables) HTML 66K
51: R35 Fair Value Measurements (Tables) HTML 255K
52: R36 Restructuring and Other Costs (Tables) HTML 147K
53: R37 Shareholders' Equity (Tables) HTML 160K
54: R38 Earnings Per Share (Tables) HTML 91K
55: R39 Income Taxes (Tables) HTML 370K
56: R40 Segment Information (Tables) HTML 159K
57: R41 Operations by Geographic Location (Tables) HTML 101K
58: R42 Share-Based Compensation (Tables) HTML 156K
59: R43 Employee Benefit Plans (Tables) HTML 47K
60: R44 Basis of Presentation and Summary of Significant HTML 92K
Accounting Policies - Narrative (Details)
61: R45 Basis of Presentation and Summary of Significant HTML 40K
Accounting Policies - Net Cash Pool Position
(Details)
62: R46 Basis of Presentation and Summary of Significant HTML 50K
Accounting Policies - Estimated Useful Lives of
Property and Equipment (Details)
63: R47 Basis of Presentation and Summary of Significant HTML 46K
Accounting Policies - Estimated Useful Lives of
Intangible Assets (Details)
64: R48 Financial Statement Details - Accounts Receivable HTML 55K
and Unbilled Services, net (Details)
65: R49 Financial Statement Details - Narrative (Details) HTML 50K
66: R50 Financial Statement Details - Schedule of Property HTML 58K
and Equipment, Net (Details)
67: R51 Financial Statement Details - Schedule of Goodwill HTML 57K
(Details)
68: R52 Financial Statement Details - Schedule of HTML 53K
Intangible Assets (Details)
69: R53 Financial Statement Details - Schedule of Future HTML 51K
Amortization Expense (Details)
70: R54 Financial Statement Details - Schedule of Accrued HTML 57K
Expenses (Details)
71: R55 Financial Statement Details - Accumulated Other HTML 54K
Comprehensive Loss, Net of Taxes (Details)
72: R56 Financial Statement Details - Tax Effects HTML 59K
Allocated to Each Component of Other Comprehensive
(Loss) Income (Details)
73: R57 Financial Statement Details - Transaction and HTML 46K
Integration-Related Expenses (Details)
74: R58 Financial Statement Details - Schedule of Other HTML 48K
(Income) Expense, Net (Details)
75: R59 Financial Statement Details - Supplemental Cash HTML 52K
Flow Information (Details)
76: R60 Business Combinations and Divestitures - Narrative HTML 92K
(Details)
77: R61 Business Combinations and Divestitures - HTML 78K
Allocation of Consideration Transferred (Details)
78: R62 Business Combinations and Divestitures - HTML 47K
Preliminary Estimates of Fair Value of Intangible
Assets and Estimated Useful Lives (Details)
79: R63 Long-Term Debt Obligations - Schedule of Debt HTML 65K
Obligations (Details)
80: R64 Long-Term Debt Obligations - Narrative (Details) HTML 126K
81: R65 Long-Term Debt Obligations - Schedule of Variable HTML 58K
Rate Margins (Details)
82: R66 Long-Term Debt Obligations - Accounts Receivable HTML 67K
Financing Agreement (Details)
83: R67 Long-Term Debt Obligations - Contractual HTML 59K
Maturities of Debt Obligations (Details)
84: R68 Leases - Narrative (Details) HTML 42K
85: R69 Leases - Components of Lease Cost (Details) HTML 51K
86: R70 Leases - Supplemental Balance Sheet Information HTML 48K
Related to Leases (Details)
87: R71 Leases - Supplemental Cash Flow Information HTML 48K
Related to Leases (Details)
88: R72 Leases - Supplemental Cash Flow Information, HTML 44K
Weighted Average (Details)
89: R73 Leases - Maturities of Lease Liabilities (Details) HTML 88K
90: R74 Derivatives - Narrative (Details) HTML 60K
91: R75 Derivatives - Interest Rate Swaps Designated as HTML 53K
Hedging Instruments on Consolidated Balance Sheets
(Details)
92: R76 Fair Value Measurements - Schedule of Assets and HTML 68K
Liabilities Measured at Fair Value on a Recurring
Basis (Details)
93: R77 Fair Value Measurements - Schedule of Assets and HTML 44K
Liabilities Measured at Fair Value on a Recurring
Basis (Parenthetical) (Details)
94: R78 Fair Value Measurements - Reconciliation of HTML 42K
Changes in the Carrying Amount of Contingent
Consideration (Details)
95: R79 Fair Value Measurements - Narrative (Details) HTML 57K
96: R80 Fair Value Measurements - Schedule of Estimated HTML 55K
Fair Value (Details)
97: R81 Restructuring and Other Costs - Merger Related HTML 51K
Restructuring (Details)
98: R82 Restructuring and Other Costs - Non-Merger Related HTML 45K
Restructuring and Other Costs (Details)
99: R83 Restructuring and Other Costs - Schedule of HTML 62K
Restructuring and Related Costs (Details) -
Business Restructuring Reserves
100: R84 Shareholders' Equity - Shares of Common Stock HTML 43K
Outstanding (Details)
101: R85 Shareholders' Equity - Narrative (Details) HTML 58K
102: R86 Shareholders' Equity - Repurchase Activity HTML 45K
(Details)
103: R87 Shareholders' Equity - Schedule of Stock by Class HTML 58K
(Details)
104: R88 Earnings Per Share - Schedule of Earnings Per HTML 69K
Share, Basic and Diluted (Details)
105: R89 Earnings Per Share - Narrative (Details) HTML 37K
106: R90 Income Taxes - Components of Income before HTML 45K
Provision for Income Taxes (Details)
107: R91 Income Taxes - Schedule of Components of Income HTML 58K
Tax Expense (Benefit) (Details)
108: R92 Income Taxes - Narrative (Details) HTML 79K
109: R93 Income Taxes - Schedule of Effective Income Tax HTML 81K
Rate Reconciliation (Details)
110: R94 Income Taxes - Summary of Valuation Allowance HTML 51K
(Details)
111: R95 Income Taxes - Schedule of Deferred Tax Assets and HTML 81K
Liabilities (Details)
112: R96 Income Taxes - Schedule of Unrecognized Tax HTML 51K
Benefits (Details)
113: R97 Revenue from Contracts with Customers - Narrative HTML 47K
(Details)
114: R98 Segment Information (Details) HTML 79K
115: R99 Operations by Geographic Location - Total Revenue HTML 58K
by Geographic Area (Details)
116: R100 Operations by Geographic Location - Long-Lived HTML 48K
Assets by Geographic Area (Details)
117: R101 Concentration of Credit Risk - Narrative (Details) HTML 43K
118: R102 Related-Party Transactions - Narrative (Details) HTML 53K
119: R103 Commitments and Contingencies - Narrative HTML 51K
(Details)
120: R104 Share-Based Compensation - Narrative (Details) HTML 85K
121: R105 Share-Based Compensation - Stock Option Valuation HTML 48K
Assumptions (Details)
122: R106 Share-Based Compensation - Summary of Option HTML 86K
Activity (Details)
123: R107 Share-Based Compensation - Summary of Restricted HTML 58K
Stock Unit Activity (Details)
124: R108 Share-Based Compensation - Summary of Share-Based HTML 45K
Compensation Expense (Details)
125: R109 Employee Benefit Plans - Schedule of Contributions HTML 37K
to Defined Contribution Plan (Details)
126: R110 Employee Benefit Plans - Narrative (Details) HTML 49K
128: XML IDEA XML File -- Filing Summary XML 244K
16: XML XBRL Instance -- synh-10k_20201231_htm XML 6.10M
127: EXCEL IDEA Workbook of Financial Reports XLSX 175K
12: EX-101.CAL XBRL Calculations -- synh-20201231_cal XML 372K
13: EX-101.DEF XBRL Definitions -- synh-20201231_def XML 1.05M
14: EX-101.LAB XBRL Labels -- synh-20201231_lab XML 2.16M
15: EX-101.PRE XBRL Presentations -- synh-20201231_pre XML 1.77M
11: EX-101.SCH XBRL Schema -- synh-20201231 XSD 276K
129: JSON XBRL Instance as JSON Data -- MetaLinks 635± 1.01M
130: ZIP XBRL Zipped Folder -- 0001564590-21-006471-xbrl Zip 652K
 | Download this Microsoft® Excel® .xlsx workbook |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/16/23 Syneos Health, Inc. 10-K 12/31/22 136:28M Donnelley … Solutions/FA 2/17/22 Syneos Health, Inc. 10-K 12/31/21 134:25M ActiveDisclosure/FA 6/04/21 Syneos Health, Inc. 424B7 1:390K Donnelley … Solutions/FA 5/05/21 Syneos Health, Inc. 424B7 1:398K Donnelley … Solutions/FA 4/29/21 Syneos Health, Inc. 10-Q 3/31/21 84:9M ActiveDisclosure/FA 3/03/21 Syneos Health, Inc. 424B7 1:405K Donnelley … Solutions/FA |